{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:26:21Z","timestamp":1791721581326,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81660486"],"award-info":[{"award-number":["81660486"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004772","name":"Natural Science Foundation of Ningxia","doi-asserted-by":"crossref","award":["2022AAC02027"],"award-info":[{"award-number":["2022AAC02027"]}],"id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Key Research and Development Projects in Ningxia Hui Autonomous Region","award":["2023BEG02033"],"award-info":[{"award-number":["2023BEG02033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06322-8","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T09:54:48Z","timestamp":1742291688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Wnt5a augments intracellular free cholesterol levels and promotes castration resistance in prostate cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Yuqi","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lintao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxiu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0718-4992","authenticated-orcid":false,"given":"Yujing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"issue":"1","key":"6322_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023.[J]. Cancer J Clin. 2023;73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"Cancer J Clin"},{"issue":"9","key":"6322_CR2","doi-asserted-by":"publisher","first-page":"e1007344","DOI":"10.1371\/journal.pcbi.1007344","volume":"15","author":"Z Ji","year":"2019","unstructured":"Ji Z, Zhao W, Lin HK, Zhou X. Systematically Understanding the immunity leading to CRPC progression.[J]. PLoS Comput Biol. 2019;15(9):e1007344. https:\/\/doi.org\/10.1371\/journal.pcbi.1007344.","journal-title":"PLoS Comput Biol"},{"issue":"10","key":"6322_CR3","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.1002\/cam4.1735","volume":"7","author":"M Onozawa","year":"2018","unstructured":"Onozawa M, Akaza H, Hinotsu S, Oya M, Ogawa O, Kitamura T, et al. Combined androgen Blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: analysis of community-based multi-institutional database across Japan using propensity score matching.[J]. Cancer Med. 2018;7(10):4893\u2013902. https:\/\/doi.org\/10.1002\/cam4.1735.","journal-title":"Cancer Med"},{"key":"6322_CR4","doi-asserted-by":"publisher","unstructured":"Hotte SJ, Saad F. Current management of castrate-resistant prostate cancer.[J]. Current oncology (Toronto, Ont.), 2010:S72\u20139;https:\/\/doi.org\/10.3747\/co.v17i0.718","DOI":"10.3747\/co.v17i0.718"},{"issue":"49","key":"6322_CR5","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.1038\/onc.2013.206","volume":"32","author":"T Karantanos","year":"2013","unstructured":"Karantanos T, Corn PG, Thompson TC. Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches.[J]. Oncogene. 2013;32(49):5501\u201311. https:\/\/doi.org\/10.1038\/onc.2013.206.","journal-title":"Oncogene"},{"issue":"8","key":"6322_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5306\/wjco.v10.i8.283","volume":"10","author":"G Ozyigit","year":"2019","unstructured":"Ozyigit G, Hurmuz P, Yuce D, Akyol F. Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer.[J]. World J Clin Oncol. 2019;10(8):283\u201392. https:\/\/doi.org\/10.5306\/wjco.v10.i8.283.","journal-title":"World J Clin Oncol"},{"issue":"6","key":"6322_CR7","doi-asserted-by":"publisher","first-page":"e1107","DOI":"10.1016\/j.clgc.2017.07.023","volume":"15","author":"S Yamamoto","year":"2017","unstructured":"Yamamoto S, Sakamoto S, Minhui X, Tamura T, Otsuka K, Sato K, et al. Testosterone reduction of \u2265\u2009480 Ng\/dL predicts favorable prognosis of Japanese men with advanced prostate Cancer treated with Androgen-Deprivation Therapy.[J]. Clin Genitourin Cancer. 2017;15(6):e1107\u201315. https:\/\/doi.org\/10.1016\/j.clgc.2017.07.023.","journal-title":"Clin Genitourin Cancer"},{"issue":"11","key":"6322_CR8","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/j.1742-1241.2011.02799.x","volume":"65","author":"M Kirby","year":"2011","unstructured":"Kirby M, Hirst C, Crawford ED. Characterising the castration-resistant prostate cancer population: a systematic review.[J]. Int J Clin Pract. 2011;65(11):1180\u201392. https:\/\/doi.org\/10.1111\/j.1742-1241.2011.02799.x.","journal-title":"Int J Clin Pract"},{"issue":"1","key":"6322_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.clgc.2016.08.018","volume":"15","author":"DM Moreira","year":"2017","unstructured":"Moreira DM, Howard LE, Sourbeer KN, Amarasekara HS, Chow LC, Cockrell DC, et al. Predicting time from metastasis to overall survival in Castration-Resistant prostate cancer: results from SEARCH.[J]. Clin Genitourin Cancer. 2017;15(1):60\u20136. https:\/\/doi.org\/10.1016\/j.clgc.2016.08.018.","journal-title":"Clin Genitourin Cancer"},{"issue":"24","key":"6322_CR10","doi-asserted-by":"publisher","first-page":"5915","DOI":"10.7150\/jca.34564","volume":"10","author":"I Carneiro","year":"2019","unstructured":"Carneiro I, Quintela-Vieira F, Lobo J, Moreira-Barbosa C, Menezes FD, Martins AT, et al. Expression of EMT-Related genes CAMK2N1 and WNT5A is increased in locally invasive and metastatic prostate Cancer.[J]. J Cancer. 2019;10(24):5915\u201325. https:\/\/doi.org\/10.7150\/jca.34564.","journal-title":"J Cancer"},{"key":"6322_CR11","doi-asserted-by":"publisher","first-page":"0doi","DOI":"10.1084\/jem.20180661","volume":"216","author":"D Ren","year":"2018","unstructured":"Ren D, Dai Y, Yang Q, Zhang X, Guo W, Ye L, et al. Wnt5a induces and maintains prostate cancer cells dormancy in bone[. J] J Exp Med. 2018;216:0doi. https:\/\/doi.org\/10.1084\/jem.20180661.","journal-title":"J] J Exp Med"},{"issue":"6","key":"6322_CR12","doi-asserted-by":"publisher","first-page":"9572","DOI":"10.18632\/oncotarget.14161","volume":"8","author":"E Sandsmark","year":"2017","unstructured":"Sandsmark E, Hansen AF, Seln\u00e6s KM, Bertilsson H, Bofin AM, Wright AJ, Viset T, Richardsen E, Drabl\u00f8s F, Bathen TF, Tessem, et al. A novel non-canonical Wnt signature for prostate cancer aggressiveness.[J]. Oncotarget. 2017;8(6):9572\u201386. https:\/\/doi.org\/10.18632\/oncotarget.14161.","journal-title":"Oncotarget"},{"issue":"1","key":"6322_CR13","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/s41467-018-04042-w","volume":"9","author":"V Murillo-Garz\u00f3n","year":"2018","unstructured":"Murillo-Garz\u00f3n V, Gorro\u00f1o-Etxebarria I, \u00c5kerfelt M, Puustinen MC, Sistonen L, Nees M, et al. Frizzled-8 integrates Wnt-11 and transforming growth factor-\u03b2 signaling in prostate cancer.[J]. Nat Commun. 2018;9(1):1747. https:\/\/doi.org\/10.1038\/s41467-018-04042-w.","journal-title":"Nat Commun"},{"issue":"12","key":"6322_CR14","doi-asserted-by":"publisher","first-page":"e0188842","DOI":"10.1371\/journal.pone.0188842","volume":"12","author":"D J\u0119droszka","year":"2017","unstructured":"J\u0119droszka D, Orzechowska M, Hamouz R, G\u00f3rniak K, Bednarek AK. Markers of epithelial-to-mesenchymal transition reflect tumor biology according to patient age and Gleason score in prostate cancer.[J]. PLoS ONE. 2017;12(12):e0188842. https:\/\/doi.org\/10.1371\/journal.pone.0188842.","journal-title":"PLoS ONE"},{"key":"6322_CR15","doi-asserted-by":"publisher","unstructured":"Arisan ED, Rencuzogullari O, Freitas IL, Radzali S, Keskin B, Kothari A, et al. Upregulated Wnt-11 and miR-21 expression trigger epithelial mesenchymal transition in aggressive. Prostate Cancer Cells [J] Biology. 2020;9(3). https:\/\/doi.org\/10.3390\/biology9030052.","DOI":"10.3390\/biology9030052"},{"key":"6322_CR16","doi-asserted-by":"publisher","first-page":"9257","DOI":"10.2147\/OTT.S245861","volume":"13","author":"J Luo","year":"2020","unstructured":"Luo J, Wang D, Wan X, Xu Y, Lu Y, Kong Z, et al. Crosstalk between AR and Wnt signaling promotes Castration-Resistant. Prostate Cancer Growth [J] Onco Targets Ther. 2020;13:9257\u201367. https:\/\/doi.org\/10.2147\/OTT.S245861.","journal-title":"Prostate Cancer Growth [J] Onco Targets Ther"},{"issue":"12","key":"6322_CR17","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1002\/art.42304","volume":"74","author":"XF Wang","year":"2022","unstructured":"Wang XF, Xu WJ, Wang FF, Leng R, Yang XK, Ling HZ, et al. Telomere length and development of systemic lupus erythematosus: A Mendelian randomization Study[J]. Arthritis Rheumatol. 2022;74(12):1984\u201390. https:\/\/doi.org\/10.1002\/art.42304.","journal-title":"Arthritis Rheumatol"},{"key":"6322_CR18","doi-asserted-by":"publisher","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome[J]. Elife. 2018;7. https:\/\/doi.org\/10.7554\/eLife.34408.","DOI":"10.7554\/eLife.34408"},{"issue":"5","key":"6322_CR19","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, et al. Detection of widespread horizontal Pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases[J]. Nat Genet. 2018;50(5):693\u20138. https:\/\/doi.org\/10.1038\/s41588-018-0099-7.","journal-title":"Nat Genet"},{"issue":"4","key":"6322_CR20","first-page":"292","volume":"9","author":"CM Armstrong","year":"2021","unstructured":"Armstrong CM, Gao AC. Dysregulated androgen synthesis and anti-androgen resistance in advanced prostate cancer. Am J Clin Exp Urol. 2021;9(4):292\u2013300. PMID:34541028.","journal-title":"Am J Clin Exp Urol"},{"key":"6322_CR21","doi-asserted-by":"publisher","unstructured":"Dufour J, Viennois E, De Boussac H, Baron S, Lobaccaro JM. Oxysterol receptors, AKT and prostate cancer.[J]. Curr Opin Pharmacol. 2012;12. https:\/\/doi.org\/10.1016\/j.coph.2012.06.012.","DOI":"10.1016\/j.coph.2012.06.012"},{"key":"6322_CR22","doi-asserted-by":"publisher","unstructured":"Le NT, Abe JI. Regulation of Kir2.1 function under shear stress and cholesterol Loading.[J]. J Am Heart Assoc. 2018;7. https:\/\/doi.org\/10.1161\/JAHA.118.008749.","DOI":"10.1161\/JAHA.118.008749"},{"issue":"24","key":"6322_CR23","doi-asserted-by":"publisher","first-page":"5915","DOI":"10.7150\/jca.34564","volume":"10","author":"I Carneiro","year":"2019","unstructured":"Carneiro I, Quintela-Vieira F, Lobo J, Moreira-Barbosa C, Menezes FD, Martins AT, Oliveira J, Silva R, Jer\u00f3nimo C, Henrique R. Expression of EMT-Related Genes CAMK2N1 and WNT5A is increased in Locally Invasive and Metastatic Prostate Cancer. J Cancer. 2019;10(24):5915-25. https:\/\/doi.org\/10.7150\/jca.34564","journal-title":"J Cancer"},{"issue":"1","key":"6322_CR24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13046-016-0421-0","volume":"35","author":"CP Prasad","year":"2016","unstructured":"Prasad CP, Chaurasiya SK, Guilmain W, Andersson T. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition[J]. J Exp Clin Cancer Res. 2016;35(1):144. https:\/\/doi.org\/10.1186\/s13046-016-0421-0.","journal-title":"J Exp Clin Cancer Res"},{"key":"6322_CR25","doi-asserted-by":"publisher","unstructured":"Wang B, Tang Z, Gong H, Zhu L, Liu X. Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer[J]. Biosci Rep. 2017;37(6). https:\/\/doi.org\/10.1042\/BSR20171092.","DOI":"10.1042\/BSR20171092"},{"issue":"1","key":"6322_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12964-020-00557-2","volume":"18","author":"Q Liu","year":"2020","unstructured":"Liu Q, Yang C, Wang S, Shi D, Wei C, Song J, et al. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression[J]. Cell Commun Signal. 2020;18(1):51. https:\/\/doi.org\/10.1186\/s12964-020-00557-2.","journal-title":"Cell Commun Signal"},{"issue":"17","key":"6322_CR27","doi-asserted-by":"publisher","first-page":"8388","DOI":"10.1158\/0008-5472.CAN-07-0617","volume":"67","author":"MC Hodgson","year":"2007","unstructured":"Hodgson MC, Astapova I, Hollenberg AN, Balk SP. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.[J]. Cancer Res. 2007;67(17):8388\u201395. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-0617.","journal-title":"Cancer Res"},{"key":"6322_CR28","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3389\/fonc.2019.00858","volume":"9","author":"Q Feng","year":"2019","unstructured":"Feng Q, He B. Androgen receptor signaling in the development of Castration-Resistant prostate Cancer.[J]. Front Oncol. 2019;9:858. https:\/\/doi.org\/10.3389\/fonc.2019.00858.","journal-title":"Front Oncol"},{"key":"6322_CR29","doi-asserted-by":"publisher","unstructured":"Penning TM. Dehydroepiandrosterone (DHEA)-SO(4) depot and Castration-Resistant prostate Cancer.[J]. Vitam Horm. 2018;108. https:\/\/doi.org\/10.1016\/bs.vh.2018.01.007.","DOI":"10.1016\/bs.vh.2018.01.007"},{"issue":"1","key":"6322_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.apsb.2019.11.016","volume":"10","author":"J Lu","year":"2020","unstructured":"Lu J, Shang X, Zhong W, Xu Y, Shi R, Wang X. New insights of CYP1A in endogenous metabolism: a focus on single nucleotide polymorphisms and diseases. Acta Pharm Sin B. 2020;10(1):91\u2013104. https:\/\/doi.org\/10.1016\/j.apsb.2019.11.016.","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"6322_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nrurol.2017.201","volume":"15","author":"D Hettel","year":"2018","unstructured":"Hettel D, Sharifi N. HSD3B1 status as a biomarker of androgen deprivation resistance and implications for prostate cancer[J]. Nat Rev Urol. 2018;15(3):191\u20136. https:\/\/doi.org\/10.1038\/nrurol.2017.201.","journal-title":"Nat Rev Urol"},{"key":"6322_CR32","doi-asserted-by":"publisher","unstructured":"Hakkarainen J, Zhang FP, Jokela H, Mayerhofer A, Behr R, Cisneros-Montalvo S et al. Hydroxysteroid (17\u03b2) dehydrogenase 1 expressed by Sertoli cells contributes to steroid synthesis and is required for male fertility.[J]. FASEB journal: official publication of the federation of American societies for experimental biology, 2018,32(6):3229\u201341; https:\/\/doi.org\/10.1096\/fj.201700921R","DOI":"10.1096\/fj.201700921R"},{"issue":"1","key":"6322_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1042\/BJ20101804","volume":"437","author":"Y Jin","year":"2011","unstructured":"Jin Y, Mesaros AC, Blair IA, Penning TM. Stereospecific reduction of 5beta-reduced steroids by human ketosteroid reductases of the AKR (aldo-keto reductase) superfamily: role of AKR1C1-AKR1C4 in the metabolism of testosterone and progesterone via the 5beta-reductase pathway[J]. Biochem J. 2011;437(1):53\u201361. https:\/\/doi.org\/10.1042\/BJ20101804.","journal-title":"Biochem J"},{"key":"6322_CR34","doi-asserted-by":"publisher","unstructured":"Yu L, Li RW, Huang H, Pham Q, Yu L, Wang TTY. Transcriptomic analysis of LNCaP tumor xenograft to elucidate the components and mechanisms contributed by tumor environment as targets for dietary prostate Cancer prevention Studies[J]. Nutrients. 2021;13(3). https:\/\/doi.org\/10.3390\/nu13031000.","DOI":"10.3390\/nu13031000"},{"key":"6322_CR35","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3389\/fendo.2018.00715","volume":"9","author":"EE Morin","year":"2018","unstructured":"Morin EE, Li XA, Schwendeman A. HDL in endocrine carcinomas: biomarker, drug carrier, and potential Therapeutic.[J]. Front Endocrinol. 2018;9:715. https:\/\/doi.org\/10.3389\/fendo.2018.00715.","journal-title":"Front Endocrinol"},{"issue":"1","key":"6322_CR36","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1038\/s41598-018-19568-8","volume":"8","author":"M Ruscica","year":"2018","unstructured":"Ruscica M, Botta M, Ferri N, Giorgio E, Macchi C, Franceschini G, et al. High density lipoproteins inhibit oxidative Stress-Induced prostate Cancer cell Proliferation.[J]. Sci Rep. 2018;8(1):2236. https:\/\/doi.org\/10.1038\/s41598-018-19568-8.","journal-title":"Sci Rep"},{"issue":"2","key":"6322_CR37","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41391-017-0030-9","volume":"21","author":"J Jamnagerwalla","year":"2018","unstructured":"Jamnagerwalla J, Howard LE, Allott EH, Vidal AC, Moreira DM, Castro-Santamaria R, et al. Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study.[J]. Prostate Cancer Prostatic Dis. 2018;21(2):252\u20139. https:\/\/doi.org\/10.1038\/s41391-017-0030-9.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"6322_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41391-018-0087-0","volume":"22","author":"TJ Murtola","year":"2019","unstructured":"Murtola TJ, Kasurinen TVJ, Talala K, Taari K, Tammela TLJ, Auvinen A. Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer. Prostate Cancer Prostatic Dis. 2019;22(1):66\u201376. https:\/\/doi.org\/10.1038\/s41391-018-0087-0","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"3","key":"6322_CR39","doi-asserted-by":"publisher","first-page":"229","DOI":"10.56434\/j.arch.esp.urol.20247703.30","volume":"77","author":"P Hu","year":"2024","unstructured":"Hu P, Cheng R, Chen G, Hu X, Shen Y. Low-Density Lipoprotein Cholesterol and Prostate Cancer: A Retrospective Study. Arch Esp Urol. 2024;77(3):229\u201334. https:\/\/doi.org\/10.56434\/j.arch.esp.urol.20247703.30","journal-title":"Arch Esp Urol."},{"issue":"4","key":"6322_CR40","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/pros.21072","volume":"70","author":"CG Leon","year":"2010","unstructured":"Leon CG, Locke JA, Adomat HH, Etinger SL, Twiddy AL, Neumann RD, et al. Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration-resistant prostate cancer in a mouse xenograft model. Prostate. 2010;70(4):390\u2013400. https:\/\/doi.org\/10.1002\/pros.21072.","journal-title":"Prostate"},{"issue":"7","key":"6322_CR41","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.1002\/jcp.30229","volume":"236","author":"YY Jung","year":"2021","unstructured":"Jung YY, Ko JH, Um JY, Chinnathambi A, Alharbi SA, Sethi G, et al. LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway[J]. J Cell Physiol. 2021;236(7):5253\u201364. https:\/\/doi.org\/10.1002\/jcp.30229.","journal-title":"J Cell Physiol"},{"issue":"10","key":"6322_CR42","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/pros.20593","volume":"67","author":"HY Oh","year":"2007","unstructured":"Oh HY, Lee EJ, Yoon S, Chung BH, Cho KS, Hong SJ. Cholesterol level of lipid raft microdomains regulates apoptotic cell death in prostate cancer cells through EGFR-mediated Akt and ERK signal transduction[J]. Prostate. 2007;67(10):1061\u20139. https:\/\/doi.org\/10.1002\/pros.20593.","journal-title":"Prostate"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06322-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06322-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06322-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T21:02:03Z","timestamp":1755032523000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06322-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6322"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06322-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and approved by the Ethics Committee of Ningxia Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"347"}}